8-K: Venus Concept Reports Q4 and Fiscal Year 2024 Financial Results, Announces Additional Financing

Venus Concept announced its Q4 and fiscal year 2024 financial results, highlighting a reduction in debt and operational cash use, alongside an amendment to its Bridge Loan Agreement for additional financing.

Summary

• Venus Concept reported a 13% year-over-year decrease in Q4 revenue, totaling $15.8 million.
• The company's operating expenses for Q4 decreased by 11% year-over-year.
• The net loss attributable to stockholders for Q4 2024 was $8.0 million, an improvement from the $11.1 million loss in Q4 2023.
• Adjusted EBITDA loss for Q4 2024 was $6.1 million, compared to a $5.9 million loss in the same period last year.
• For fiscal year 2024, total revenue decreased by 15% to $64.8 million.
• The company reduced its outstanding debt from $74.9 million to $39.7 million, a 47% year-over-year decrease.
• Cash used in operations in 2024 was $11.1 million, a 14% reduction year-over-year.
• The company expects total revenue for the three months ending March 31, 2025, to be at least $14.0 million.
• On March 27, 2025, the company amended its Bridge Loan Agreement with Madryn to create an additional $10.0 million of financing capacity.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company has made progress in reducing debt and operational costs, revenue is down and the company is relying on additional financing. The lack of full-year guidance also adds uncertainty.

Positives

• The company achieved a substantial reduction in outstanding debt, decreasing it by 47% year-over-year.
• Cash used in operations decreased by 14% year-over-year, indicating improved efficiency.
• Operating expenses for the fourth quarter declined by 11% year-over-year, reflecting cost containment efforts.
• The net loss attributable to stockholders improved by 28% year-over-year in the fourth quarter.
• The company regained compliance with Nasdaq's minimum bid-price listing standard.

Negatives

• Total revenue for the fourth quarter decreased by 13% year-over-year.
• Adjusted EBITDA loss for the fourth quarter was $6.1 million, slightly worse than the $5.9 million loss in the previous year.
• Total revenue for fiscal year 2024 decreased by 15% compared to fiscal year 2023.
• The decrease in total revenue was driven primarily by a 35% decrease in lease revenue and a 9% decrease in products systems revenue.

Risks

• The company acknowledges difficulties in the industry impacted Q4 results relative to expectations.
• The company is not providing full year 2025 financial guidance at this time, indicating uncertainty.
• The company's reliance on additional financing, such as the amended Bridge Loan Agreement, suggests potential financial strain.
• The decrease in revenue from Venus Prime/Subscription Systems indicates a potential shift in customer preference or market dynamics.

Future Outlook

The company expects total revenue for the three months ending March 31, 2025, to be at least $14.0 million. However, it is not providing full year 2025 financial guidance at this time due to ongoing discussions with lenders and investors and evaluation of strategic alternatives.

Management Comments

• 'Difficulties in the industry persisted in the fourth quarter and impacted our results relative to the expectations we outlined during our third quarter report,' said Rajiv De Silva, Chief Executive Officer of Venus Concept.
• Management's focus remains on reducing cash burn through disciplined cost management and targeted investments to regain business growth.
• Management appreciates the continued partnership with Madryn, as evidenced by the latest bridge loan amendment.

Industry Context

The medical aesthetics industry is competitive and subject to changing consumer preferences and technological advancements. Venus Concept's results reflect broader industry challenges, as noted by management. The company's focus on cost management and strategic investments aligns with common strategies for navigating such challenges.

Comparison to Industry Standards

• Comparing Venus Concept's performance to industry peers is challenging without specific competitor data in this release.
• Companies like Cutera, Candela, and Cynosure are key players in the medical aesthetics market.
• Cutera reported revenue of $71.4 million in Q3 2024, while Candela reported revenue of $123.7 million in Q3 2024.
• Venus Concept's $15.8 million in Q4 revenue is significantly lower than these competitors, indicating a smaller market share.
• The debt reduction strategy is a positive step, as many companies in this sector carry significant debt loads to fund innovation and expansion.
• The adjusted EBITDA loss suggests that Venus Concept needs to improve operational efficiency to align with industry benchmarks.

Stakeholder Impact

• Shareholders may be concerned about the revenue decline and ongoing losses.
• Employees may be affected by the company's cost containment and restructuring efforts.
• Customers may experience changes in product offerings or service quality as the company adjusts its strategy.
• Creditors are impacted by the debt reduction and ongoing financing activities.

Next Steps

• The company will host a conference call on March 31, 2025, to discuss the results.
• The company will continue its active dialogue with existing lenders and investors.
• The company will continue evaluating strategic alternatives to maximize shareholder value.

Key Dates

Keywords

financial results, revenue, EBITDA, debt reduction, financing, medical aesthetics, Venus Concept